Skip to main content

Sherene Loi, MBBS, PhD

Sherene Loi, MBBS, PhD, Peter MacCallum Cancer Center
Videos
10/21/2023
At the 2023 ESMO Annual Congress, Sherene Loi shares results from the CheckMate 7FL trial evaluating nivolumab vs placebo plus neoadjuvant chemotherapy among patients with high-risk, ER-positive/HER2-negative breast cancer.
At the 2023 ESMO Annual Congress, Sherene Loi shares results from the CheckMate 7FL trial evaluating nivolumab vs placebo plus neoadjuvant chemotherapy among patients with high-risk, ER-positive/HER2-negative breast cancer.
At the 2023 ESMO Annual...
10/21/2023
Oncology